On October 30, 2020, Market Scope invited 891 US ophthalmologists via our online survey portal to participate in part seven of a nine-part series of surveys to capture the impact of COVID-19 on ophthalmic practices. There were 117 participants, representing 33 states. This survey attracted a diverse group of doctors; 85 percent of respondents provide cataract surgery, 63 percent perform glaucoma surgery, 29 percent treat retina patients, and 31 percent provide cornea treatment. Most of these doctors offer multiple areas of treatment. All individual responses are kept strictly confidential, and we report only aggregate data.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.